Everest Organics Limited (BOM:524790)
404.00
-11.25 (-2.71%)
At close: Jan 21, 2026
Everest Organics Revenue
Everest Organics had revenue of 512.92M INR in the quarter ending September 30, 2025, with 16.08% growth. This brings the company's revenue in the last twelve months to 1.89B, up 3.42% year-over-year. In the fiscal year ending March 31, 2025, Everest Organics had annual revenue of 1.60B, down -19.23%.
Revenue (ttm)
1.89B
Revenue Growth
+3.42%
P/S Ratio
2.07
Revenue / Employee
5.31M
Employees
355
Market Cap
3.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.60B | -380.70M | -19.23% |
| Mar 31, 2024 | 1.98B | 141.55M | 7.70% |
| Mar 31, 2023 | 1.84B | -177.25M | -8.79% |
| Mar 31, 2022 | 2.02B | 195.19M | 10.72% |
| Mar 31, 2021 | 1.82B | 141.64M | 8.44% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sudarshan Pharma Industries | 5.92B |
| ZIM Laboratories | 3.66B |
| Albert David | 3.16B |
| Amanta Healthcare | 2.76B |
| Kilitch Drugs (India) | 2.09B |
| Medico Remedies | 1.72B |
| Medicamen Biotech | 1.70B |
| Jenburkt Pharmaceuticals | 1.59B |